EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Optimizing Rituximab Maintenance Therapy: Outcomes of Extended-Interval Dosing in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder

Supawit Kittipadakul, Tatchaporn Ongphichetmetha, Sasitorn Siritho, Ekdanai Uawithya, Naraporn Prayoonwiwat, Natthapon Rattanathamsakul, Jiraporn Jitprapaikulsan

Journal of Clinical Medicine Research · 2026-05 · 18 (5) · 301-312

DOI: 10.14740/jocmr6529 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine Research, 2026-05. Verfasst von Supawit Kittipadakul und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Anti-CD20B-cell depleting therapyMultiple sclerosisNeuromyelitis optica spectrum disorderRituximab

Autor:innen und Institutionen

  • Department of Physiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
  • Siriraj Neuroimmunology Center, Division of Neurology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
  • Division of Clinical Epidemiology, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
  • Bumrungrad International Hospital, Bangkok 10110, Thailand.
  • Division of Neurology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.

Zitieren

APA

Kittipadakul, S., Ongphichetmetha, T., Siritho, S., Uawithya, E., Prayoonwiwat, N., Rattanathamsakul, N., & Jitprapaikulsan, J. (2026). Optimizing Rituximab Maintenance Therapy: Outcomes of Extended-Interval Dosing in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder. Journal of Clinical Medicine Research, 18(5), 301-312. https://doi.org/10.14740/jocmr6529

Vancouver

Kittipadakul S, Ongphichetmetha T, Siritho S, Uawithya E, Prayoonwiwat N, Rattanathamsakul N, et al. Optimizing Rituximab Maintenance Therapy: Outcomes of Extended-Interval Dosing in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder. Journal of Clinical Medicine Research. 2026;18(5):301-312. doi:10.14740/jocmr6529

BibTeX
@article{Kittipadakul2026,
  author = {Kittipadakul, Supawit and Ongphichetmetha, Tatchaporn and Siritho, Sasitorn and Uawithya, Ekdanai and Prayoonwiwat, Naraporn and Rattanathamsakul, Natthapon and Jitprapaikulsan, Jiraporn},
  title = {Optimizing Rituximab Maintenance Therapy: Outcomes of Extended-Interval Dosing in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder},
  journal = {Journal of Clinical Medicine Research},
  year = {2026},
  volume = {18},
  number = {5},
  pages = {301--312},
  doi = {10.14740/jocmr6529}
}
Kostenlos starten →